DE60034662D1 - Behandlung von unfruchtbarkeit - Google Patents

Behandlung von unfruchtbarkeit

Info

Publication number
DE60034662D1
DE60034662D1 DE60034662T DE60034662T DE60034662D1 DE 60034662 D1 DE60034662 D1 DE 60034662D1 DE 60034662 T DE60034662 T DE 60034662T DE 60034662 T DE60034662 T DE 60034662T DE 60034662 D1 DE60034662 D1 DE 60034662D1
Authority
DE
Germany
Prior art keywords
woman
barreness
treatment
hormone
vitro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60034662T
Other languages
English (en)
Other versions
DE60034662T2 (de
Inventor
Christian Grondahl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Application granted granted Critical
Publication of DE60034662D1 publication Critical patent/DE60034662D1/de
Publication of DE60034662T2 publication Critical patent/DE60034662T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
DE60034662T 1999-02-24 2000-02-23 Behandlung von unfruchtbarkeit Expired - Fee Related DE60034662T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DKPA199900256 1999-02-24
DK25699 1999-02-24
US13066299P 1999-04-23 1999-04-23
US130662P 1999-04-23
DKPA199901307 1999-09-16
DK130799 1999-09-16
PCT/DK2000/000073 WO2000050065A1 (en) 1999-02-24 2000-02-23 Treatment of infertility

Publications (2)

Publication Number Publication Date
DE60034662D1 true DE60034662D1 (de) 2007-06-14
DE60034662T2 DE60034662T2 (de) 2008-01-03

Family

ID=27220547

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60034662T Expired - Fee Related DE60034662T2 (de) 1999-02-24 2000-02-23 Behandlung von unfruchtbarkeit

Country Status (12)

Country Link
US (1) US6281013B1 (de)
EP (1) EP1156821B1 (de)
JP (1) JP2002537348A (de)
KR (1) KR20010093276A (de)
AT (1) ATE361091T1 (de)
AU (1) AU2794000A (de)
CA (1) CA2363074A1 (de)
CZ (1) CZ20012968A3 (de)
DE (1) DE60034662T2 (de)
ES (1) ES2286008T3 (de)
HU (1) HUP0200079A3 (de)
WO (1) WO2000050065A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60025905T2 (de) * 1999-02-24 2006-09-14 Novo Nordisk A/S In vitro methode zur synchronisation von oozytenreifung
CN1341147A (zh) * 1999-02-26 2002-03-20 诺沃挪第克公司 减数分裂活化甾醇增大着床率
US20030153808A1 (en) * 2000-02-25 2003-08-14 Christa Hegele-Hartung Implantation rate using ff-mas
WO2001062260A2 (en) * 2000-02-25 2001-08-30 Schering Aktiengesellschaft Improvement of implantation rate
JP2003533222A (ja) * 2000-05-18 2003-11-11 シエーリング アクチエンゲゼルシャフト 経年卵母細胞の受精
US6758806B2 (en) 2001-01-12 2004-07-06 Napoli, Llc Endoscopic devices and method of use
EP1351612B1 (de) * 2001-01-12 2007-10-03 Napoli, LLC Intrauterin-Mikrokatheter
US6623422B2 (en) * 2001-01-12 2003-09-23 Napoli, Llc Method and apparatus for assisted embryo implantation
US8465412B2 (en) * 2001-01-12 2013-06-18 Michael Levy Uterine devices and method of use
US20060183973A1 (en) * 2001-01-12 2006-08-17 Kamrava Michael M Endoscopic devices and method of use
EP1245572A1 (de) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol-Verbindungen, ihre Verwendung zur Herstellung Meiose-regulierender Medikamenten und ein Vefahren zu ihrer Herstellung
US7033314B2 (en) * 2002-01-11 2006-04-25 Fidelitycorp Limited Endoscopic devices and method of use
US20030135876A1 (en) * 2002-01-16 2003-07-17 Larry Mobraaten Maintenance of genetic lines using cryopreserved sperm
JP2005518823A (ja) 2002-03-08 2005-06-30 マクギル・ユニバーシテイ 未成熟ヒト卵母細胞の体外成熟
EP1550447A1 (de) * 2004-01-02 2005-07-06 Schering Aktiengesellschaft Menstruationszykluskontrolle und Verbesserung der weiblichen Empfängnisrate
JP2008512990A (ja) 2004-05-17 2008-05-01 ザ ジェネラル ホスピタル コーポレーション 骨髄由来の生殖細胞系列幹細胞から生殖細胞を産生するための方法及び組成物
CN104293646A (zh) 2009-08-22 2015-01-21 里兰斯坦福初级大学理事会 成像并评估胚胎、卵母细胞和干细胞
CA2812776C (en) 2010-09-27 2022-05-17 Auxogyn, Inc. Apparatus, method, and system for the automated imaging and evaluation of embryos, oocytes, and stem cells
WO2012116185A1 (en) 2011-02-23 2012-08-30 The Board Of Trustees Of The Leland Stanford Junior University Methods of detecting aneuploidy in human embryos
AU2012242591B2 (en) 2011-04-14 2014-10-23 The General Hospital Corporation Compositions and methods for autologous germline mitochondrial energy transfer
EP2726601B1 (de) 2011-06-29 2018-12-26 The General Hospital Corporation Zusammensetzungen und verfahren zur verbesserung des bioenergetischen status bei weiblichen keimzellen
US20150272622A1 (en) * 2011-12-22 2015-10-01 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo
CA2875038A1 (en) 2012-05-31 2013-12-05 Auxogyn, Inc. In vitro embryo blastocyst prediction methods
ES2755878T3 (es) 2013-02-01 2020-04-24 Ares Trading Sa Fenotipos anormales de singamia observados con obtención de imágenes a intervalos de tiempo preestablecidos para identificación precoz de embriones con potencial de desarrollo inferior
US10942170B2 (en) 2014-03-20 2021-03-09 Ares Trading S.A. Quantitative measurement of human blastocyst and morula morphology developmental kinetics

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4845077A (en) * 1984-04-03 1989-07-04 Serono Laboratories, Inc. Method of inducing ovulation
US5563059A (en) * 1993-02-23 1996-10-08 Genentech, Inc. Use of human inhibin and human activin to increase the number of mature primate oocytes
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
PL322106A1 (en) * 1995-03-06 1998-01-05 Novo Nordisk As Meiosis stimulation
WO1997000883A1 (en) * 1995-06-23 1997-01-09 Novo Nordisk A/S Meiosis regulating compounds
HUP9900454A3 (en) * 1995-06-23 1999-11-29 Novo Nordisk As Meiosis regulating compounds and their use
IL130249A0 (en) * 1996-12-20 2000-06-01 Novo Nordisk As Meiosis regulating compounds
PL337188A1 (en) * 1997-06-04 2000-08-14 Akzo Nobel Nv Derivatives of 17beta - allyloxy (thio) alkyl - androstane for modulation of meiosis
US5866599A (en) * 1997-06-06 1999-02-02 Basf Aktiengesellschaft Fungicidal mixtures

Also Published As

Publication number Publication date
KR20010093276A (ko) 2001-10-27
CA2363074A1 (en) 2000-08-31
ES2286008T3 (es) 2007-12-01
HUP0200079A3 (en) 2002-06-28
HUP0200079A2 (hu) 2002-05-29
DE60034662T2 (de) 2008-01-03
EP1156821B1 (de) 2007-05-02
WO2000050065A1 (en) 2000-08-31
ATE361091T1 (de) 2007-05-15
EP1156821A1 (de) 2001-11-28
JP2002537348A (ja) 2002-11-05
CZ20012968A3 (cs) 2002-01-16
AU2794000A (en) 2000-09-14
US6281013B1 (en) 2001-08-28

Similar Documents

Publication Publication Date Title
DE60034662D1 (de) Behandlung von unfruchtbarkeit
DE69022722T2 (de) Kombinationstherapie zur behandlung von estrogenempfindlichen erkrankungen.
ATE293989T1 (de) Verwendung von eph-rezeptor-antagonisten und agonisten zur behandlung von vaskulären krankheiten
DE69412807D1 (de) Einrichtung zur abgabe von elektrischen impulsen für die behandlung biologischer gewebe
DE69620241D1 (de) Gonadotropin releasing hormon- antagonisten
DE60138553D1 (de) Pharmazeutische zusammensetzung und verfahren zur behandlung von hypogonadismus
NO962665D0 (no) Forbindelser med veksthormonfrigjörende egenskaper
TR199901669T2 (xx) Erkeklerdeki ereksiyon probleminin tedavisi i�in gerekli dozaj �ekilleri ve metod.
MY113488A (en) Compounds with growth hormone releasing properties
DE69830496D1 (de) Parenterales pimaricin zur behandlung von systemischen infektionen
DE69700249D1 (de) Verfahren zur behandlung von tieren, insbesondere zur deren fütterung
Demanno et al. Steroid-induced final maturation in brook trout (Salvelinus fontinalis) oocytes in vitro: the effects of forskolin and phosphodiesterase inhibitors
EA200400427A1 (ru) Применение человеческого хорионического гонадотропина и лютеинизирующего гормона при контролируемой гиперстимуляции яичников
DE60021360D1 (de) Vegf angiogenische wachstumsfaktoren zur behandlung von peripheren neuropathie
Kwon et al. Spontaneous maturation of follicular oocytes in Rana dybowskii in vitro: Seasonal influences, progesterone production, and involvement of cAMP
DE69912422D1 (de) Methode zur behandlung von fruchtbarkeitsstörungen
Donaldson et al. Induced ovulation in coho salmon (Oncorhynchus kisutch). III. Preliminary study on the use of the antiestrogen tamoxifen
DE69818809D1 (de) Verfahren zur behandlung von narbengewebe
RU2004101971A (ru) Фармацевтические композиции, которые ингибируют пролиферацию аденом гипофиза, и способ их применения
DE69126180D1 (de) Behandlung polyzystischer ovarkrankheit
EA200000689A1 (ru) Способ получения пароксетин гидрохлорида
IS5621A (is) Fiskfóður til eldis, form samsetningar, og aðferðtil gjafar
DE60323052D1 (de) Zwei gonadotropin-freisetzende hormone und methode zur isolierung
MD1094G2 (ro) Metodă de dermatoplastie a plăgilor
DE69812084D1 (de) Verfahren zur behandlung von hyperprolaktinämia und prolaktinomen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee